Skip to main content
. 2021 Nov 2;26(21):6640. doi: 10.3390/molecules26216640

Figure 1.

Figure 1

MAO-inhibitors (Moclobemide, Selegiline, Clorgyline, Lazabemide, and Safinamide) and their common structure features.